The present study systematically depicts the immune landscape, profiles immune-related genes (IRGs), and compares systemic immune markers between KRAS-mutant and KRAS wild-type CRC patients based on TCGA, GEO and in-house dataset. Here, KRAS is linked to colorectal carcinoma.